• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Fasentin Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759401

MBS5759401 is an inhibitor targeting Fasentin. Fasentin is an inhibitor of GluT1. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Fasentin, Inhibitor
Full Product Name
Fasentin
Product Synonym Names
N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxobutanamide
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
279.643
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C11H9ClF3NO2
SMILES
CC(CC(NC1=CC=C(Cl)C(C(F)(F)F)=C1)=O)=O
CAS Number
392721-37-8
Target & IC50
GLUT1
GLUT4
In Vitro
Fasentin has been described as a modulator of GLUT-1 and GLUT-4 transporters, thus inhibiting glucose uptake in some cancer cells.

Product Categories/Family for Fasentin, inhibitor

Structure of Fasentin, inhibitor

Fasentin Inhibitor – Cat# MBS5759401

Product References and Citations for Fasentin, inhibitor

Ocaa M C, Beatriz Martinez-Poveda, Manuel Mari-Beffa, et al. Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner[J]. entific Reports, 2020, 10(1).
Ocaa M C, Beatriz Martinez-Poveda, Manuel Mari-Beffa, et al. Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner[J]. entific Reports, 2020, 10(1).
Kraus, Dominik, Reckenbeil, et al. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation[J]. Cellular Oncology, 2018.
Kraus, Dominik, Reckenbeil, et al. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation[J]. Cellular Oncology, 2018.

Other Notes

Small volumes of Fasentin, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000